Physician profile
William S Mann
NPI 1821036104
$2,454.04
in general payments reported to CMS, 2019-2025
16 companies · $599 in 2025
The $599 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $299 · 2021: $324 · 2022: $339 · 2023: $429 · 2024: $327 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $963.11 | 2019-2025 | Precision 1, Precision7, Total30 |
| Harrow Eye, LLC | $359.19 | 2024-2025 | Vevye |
| Johnson & Johnson Vision Care, INC. | $148.32 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $124.31 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $112.40 | 2023 | Clarus |
| Sun Pharmaceutical Industries INC. | $101.81 | 2023 | Cequa |
| Maculogix, INC. | $97.57 | 2021 | |
| Bausch & Lomb Americas INC. | $97.10 | 2023 | Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $93.16 | 2019 | |
| Ocular Therapeutix, INC. | $88.46 | 2024 | |
| Abbvie INC. | $75.62 | 2022 | |
| Coopervision INC. | $70.95 | 2025 | Misight Contact Lens, Biofinity Contact Lens |
| Mallinckrodt Hospital Products INC. | $55.73 | 2025 | Acthar |
| Biotissue Holdings INC. | $33.76 | 2020-2025 | |
| Carl Zeiss Meditec, INC. | $17.92 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.63 | 2024 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.